Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Synchronized Diaphragmatic Stimulation in Symptomatic Heart Failure

NCT: NCT06552637 · RECRUITING

NCT IDNCT06552637
StatusRECRUITING
Start Date2026-04-30
Completion2029-12

Brief Summary

RECOVER HF is a clinical study designed to evaluate the safety and efficacy of Synchronized Diaphragmatic Stimulation delivered using the VisONE System in the treatment of patients with heart failure.

Frequently Asked Questions

What is Synchronized Diaphragmatic Stimulation in Symptomatic Heart Failure?

Synchronized Diaphragmatic Stimulation in Symptomatic Heart Failure is a clinical trial registered under NCT06552637. Current status: RECRUITING.

What is the status of NCT06552637?

The current status of NCT06552637 (Synchronized Diaphragmatic Stimulation in Symptomatic Heart Failure) is: RECRUITING.

When did Synchronized Diaphragmatic Stimulation in Symptomatic Heart Failure start?

Synchronized Diaphragmatic Stimulation in Symptomatic Heart Failure started on 2026-04-30.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑